NASH
Study Finds 3 in 4 Overweight, Obese Adults Have Steatotic Liver Disease MASH
As much as 75% of overweight and obese individuals have steatotic liver disease, according to results of a recent ...
FEBRUARY 11, 2025
FDA Approves Resmetirom, First Drug for MASH
The FDA granted accelerated approval to the first medication for the treatment of MASH, resmetirom (Rezdiffra, ...
MARCH 15, 2024
Aldafermin Shown to Reduce ELF Scores in Patients With MASH Cirrhosis
A trial evaluating aldafermin has found it effective and largely well tolerated in patients with compensated ...
FEBRUARY 20, 2024
Combination of Noninvasive Tests Identifies Later-Stage Fibrosis in MASH
A combination of noninvasive tests can identify patients with metabolic dysfunction–associated ...
DECEMBER 22, 2023
Study Underscores Need to Evaluate for Liver Disease in Patients With C. diff
Patients with Clostridioides difficile infections who also have metabolic–dysfunction associated ...
DECEMBER 17, 2023
Real-World Data Used to Describe MASH Natural History
A longitudinal study of U.S. adults with metabolic dysfunction–associated steatohepatitis elucidates rates of ...
DECEMBER 14, 2023
Endo-Hepatology: Olympus® Ultrasound Portfolio for the Management of Patients With Liver Diseases
This article describes the emerging field of endo-hepatology, supported by recent advancements in endoscopic ...
DECEMBER 13, 2023
Pegozafermin Shows Promise for Treating MASH
The new drug pegozafermin could offer a promising treatment for patients with metabolic ...
DECEMBER 6, 2023
Societies Change Term for Fatty Liver To Focus on Steatosis
After years of discussion and review, an international working group has announced recently that they will refer to ...
AUGUST 28, 2023
Expert Picks From The Liver Meeting, Part 2
In this second installment of “Expert Picks” from The Liver Meeting 2022, Ashwani K. Singal, MD, MS, ...
APRIL 19, 2023
New Agents for NASH Show Promise for Disease Resolution
New data are supporting the use of novel agents in the treatment of NASH, according to late-breaking abstracts ...
MARCH 28, 2023
Expert Picks From ACG 2022, Part 2: Esophageal and Liver Care
Brooks D. Cash, MD, discusses his favorite research from ACG 2022, specifically innovations in esophageal and ...
JANUARY 27, 2023
